ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $574,000 | -17.2% | 105,367 | +2.0% | 0.00% | 0.0% |
Q2 2023 | $693,000 | -10.3% | 103,312 | +18.0% | 0.00% | 0.0% |
Q1 2023 | $773,000 | +74.9% | 87,531 | +51.2% | 0.00% | 0.0% |
Q4 2022 | $442,000 | -20.1% | 57,876 | -24.5% | 0.00% | 0.0% |
Q3 2022 | $553,000 | -12.4% | 76,672 | -1.7% | 0.00% | 0.0% |
Q2 2022 | $631,000 | -42.0% | 77,995 | -0.4% | 0.00% | 0.0% |
Q1 2022 | $1,087,000 | -48.2% | 78,346 | +4.7% | 0.00% | -50.0% |
Q4 2021 | $2,099,000 | -1.1% | 74,800 | +19.8% | 0.00% | 0.0% |
Q3 2021 | $2,123,000 | -5.6% | 62,456 | +13.4% | 0.00% | 0.0% |
Q2 2021 | $2,250,000 | +10.6% | 55,062 | +9.0% | 0.00% | -33.3% |
Q1 2021 | $2,034,000 | -13.3% | 50,509 | +27.3% | 0.00% | 0.0% |
Q4 2020 | $2,346,000 | +12.3% | 39,662 | -7.7% | 0.00% | -25.0% |
Q3 2020 | $2,089,000 | -6.4% | 42,970 | -6.8% | 0.00% | 0.0% |
Q2 2020 | $2,231,000 | +90.0% | 46,121 | +9.2% | 0.00% | +100.0% |
Q1 2020 | $1,174,000 | +28.4% | 42,250 | +38.3% | 0.00% | +100.0% |
Q4 2019 | $914,000 | – | 30,553 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |